" class="no-js "lang="en-US"> Omega Therapeutics - Pharmtech Focus
Tuesday, January 31, 2023
Omega Therapeutics | Pharmtech Focus

Omega Therapeutics

About Omega Therapeutics

Omega Therapeutics

At Omega Therapeutics, we are enabling the control of genomic expression to target the biological root of disease and change its course without altering nucleic acid sequences or the genetic code. We are pioneering the discovery of epigenomic targets to develop a new class of therapeutics and transform the practice of medicine.

Our culture is inspired by our values and behaviors and is guided by our overarching ethos: Ambitious, yet humble.

Our team has the burning ambition to succeed in our pioneering journey, however, we are grounded in humility given the enormous responsibility of eventually treating patients with our first-in-class and transformative medicines.

Our Omega values reflect this ethos and are hallmarks of our high-performance culture.

Related Story

Omega Therapeutics to Advance Pipeline and Platform Development with Additional Financing

March 30 2021

Omega Therapeutics, Inc. (“Omega“), a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to […]